APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Phage Display Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Phage Display Service Market Analysis and Forecast 2026-2032

5 March 2026213 pages

Choose your research edition.

Industry ResearchPhage Display Service Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Phage Display Service Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Phage Display Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phage Display Service Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Phage Display Service Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Phage Display Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Phage Display Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Phage Display Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Phage Display Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Phage Display Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Phage Display Service include Creative Biogene, Creative Biolabs, ProteoGenix, CUSABIO, Diaclone, Biomolecular Discovery Services, Charles River, GenScript and Synbio Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Phage Display Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Phage Display Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Phage Display Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Phage Display Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Phage Display Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Phage Display Service revenue, projected growth trends, production technology, application and end-user industry.

Phage Display Service Segment by Company

Creative Biogene

Creative Biolabs

ProteoGenix

CUSABIO

Diaclone

Biomolecular Discovery Services

Charles River

GenScript

Synbio Technologies

Creative Peptides

ProImmune

Absolute Antibody

Iontas

LakePharma

KMD Bioscience

NeoClone

Pepscan

Abzena

ChemPartner

Creative Proteomics

Yntoab

Diane biological

Biosynth

Zoonbio Biotechnology

Abiocenter

Phage Display Service Segment by Type

cDNA Library

Antibody Library

Protein Library

Random Peptide Library

Phage Display Service Segment by Application

Immunotherapy

Drug Discovery

Functional Genomics

Others

Phage Display Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phage Display Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phage Display Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phage Display Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Phage Display Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Phage Display Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phage Display Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Phage Display Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. cDNA Library Major Player Table 3. Antibody Library Major Player Table 4. Protein Library Major Player Table 5. Random Peptide Library Major Player Table 6. Global Phage Display Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Immunotherapy Major Player Table 8. Drug Discovery Major Player Table 9. Functional Genomics Major Player Table 10. Others Major Player Table 11. Phage Display Service Industry Trends Table 12. Phage Display Service Industry Drivers Table 13. Phage Display Service Industry Opportunities and Challenges Table 14. Phage Display Service Industry Restraints Table 15. Global Phage Display Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Phage Display Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Phage Display Service Market Share by Region (2021-2026) Table 18. Global Phage Display Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Phage Display Service Market Share by Region (2027-2032) Table 20. Global Phage Display Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Phage Display Service Revenue Market Share by Players (2021-2026) Table 22. Global Phage Display Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Phage Display Service Key Players Headquarters & Area Served Table 24. Global Phage Display Service Players, Product Type & Application Table 25. Global Phage Display Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Phage Display Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Phage Display Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Phage Display Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Phage Display Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Phage Display Service Revenue Market Share by Type (2021-2026) Table 32. Global Phage Display Service Revenue Market Share by Type (2027-2032) Table 33. Global Phage Display Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Phage Display Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Phage Display Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Phage Display Service Revenue Market Share by Application (2021-2026) Table 37. Global Phage Display Service Revenue Market Share by Application (2027-2032) Table 38. Creative Biogene Company Information Table 39. Creative Biogene Business Overview Table 40. Creative Biogene Phage Display Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Creative Biogene Phage Display Service Product Portfolio Table 42. Creative Biogene Recent Development Table 43. Creative Biolabs Company Information Table 44. Creative Biolabs Business Overview Table 45. Creative Biolabs Phage Display Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Creative Biolabs Phage Display Service Product Portfolio Table 47. Creative Biolabs Recent Development Table 48. ProteoGenix Company Information Table 49. ProteoGenix Business Overview Table 50. ProteoGenix Phage Display Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. ProteoGenix Phage Display Service Product Portfolio Table 52. ProteoGenix Recent Development Table 53. CUSABIO Company Information Table 54. CUSABIO Business Overview Table 55. CUSABIO Phage Display Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. CUSABIO Phage Display Service Product Portfolio Table 57. CUSABIO Recent Development Table 58. Diaclone Company Information Table 59. Diaclone Business Overview Table 60. Diaclone Phage Display Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Diaclone Phage Display Service Product Portfolio Table 62. Diaclone Recent Development Table 63. Biomolecular Discovery Services Company Information Table 64. Biomolecular Discovery Services Business Overview Table 65. Biomolecular Discovery Services Phage Display Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Biomolecular Discovery Services Phage Display Service Product Portfolio Table 67. Biomolecular Discovery Services Recent Development Table 68. Charles River Company Information Table 69. Charles River Business Overview Table 70. Charles River Phage Display Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Charles River Phage Display Service Product Portfolio Table 72. Charles River Recent Development Table 73. GenScript Company Information Table 74. GenScript Business Overview Table 75. GenScript Phage Display Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. GenScript Phage Display Service Product Portfolio Table 77. GenScript Recent Development Table 78. Synbio Technologies Company Information Table 79. Synbio Technologies Business Overview Table 80. Synbio Technologies Phage Display Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Synbio Technologies Phage Display Service Product Portfolio Table 82. Synbio Technologies Recent Development Table 83. Creative Peptides Company Information Table 84. Creative Peptides Business Overview Table 85. Creative Peptides Phage Display Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Creative Peptides Phage Display Service Product Portfolio Table 87. Creative Peptides Recent Development Table 88. ProImmune Company Information Table 89. ProImmune Business Overview Table 90. ProImmune Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. ProImmune Phage Display Service Product Portfolio Table 92. ProImmune Recent Development Table 93. Absolute Antibody Company Information Table 94. Absolute Antibody Business Overview Table 95. Absolute Antibody Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Absolute Antibody Phage Display Service Product Portfolio Table 97. Absolute Antibody Recent Development Table 98. Iontas Company Information Table 99. Iontas Business Overview Table 100. Iontas Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Iontas Phage Display Service Product Portfolio Table 102. Iontas Recent Development Table 103. LakePharma Company Information Table 104. LakePharma Business Overview Table 105. LakePharma Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. LakePharma Phage Display Service Product Portfolio Table 107. LakePharma Recent Development Table 108. KMD Bioscience Company Information Table 109. KMD Bioscience Business Overview Table 110. KMD Bioscience Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. KMD Bioscience Phage Display Service Product Portfolio Table 112. KMD Bioscience Recent Development Table 113. NeoClone Company Information Table 114. NeoClone Business Overview Table 115. NeoClone Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. NeoClone Phage Display Service Product Portfolio Table 117. NeoClone Recent Development Table 118. Pepscan Company Information Table 119. Pepscan Business Overview Table 120. Pepscan Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Pepscan Phage Display Service Product Portfolio Table 122. Pepscan Recent Development Table 123. Abzena Company Information Table 124. Abzena Business Overview Table 125. Abzena Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Abzena Phage Display Service Product Portfolio Table 127. Abzena Recent Development Table 128. ChemPartner Company Information Table 129. ChemPartner Business Overview Table 130. ChemPartner Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. ChemPartner Phage Display Service Product Portfolio Table 132. ChemPartner Recent Development Table 133. Creative Proteomics Company Information Table 134. Creative Proteomics Business Overview Table 135. Creative Proteomics Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Creative Proteomics Phage Display Service Product Portfolio Table 137. Creative Proteomics Recent Development Table 138. Yntoab Company Information Table 139. Yntoab Business Overview Table 140. Yntoab Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Yntoab Phage Display Service Product Portfolio Table 142. Yntoab Recent Development Table 143. Diane biological Company Information Table 144. Diane biological Business Overview Table 145. Diane biological Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Diane biological Phage Display Service Product Portfolio Table 147. Diane biological Recent Development Table 148. Biosynth Company Information Table 149. Biosynth Business Overview Table 150. Biosynth Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Biosynth Phage Display Service Product Portfolio Table 152. Biosynth Recent Development Table 153. Zoonbio Biotechnology Company Information Table 154. Zoonbio Biotechnology Business Overview Table 155. Zoonbio Biotechnology Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Zoonbio Biotechnology Phage Display Service Product Portfolio Table 157. Zoonbio Biotechnology Recent Development Table 158. Abiocenter Company Information Table 159. Abiocenter Business Overview Table 160. Abiocenter Phage Display Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Abiocenter Phage Display Service Product Portfolio Table 162. Abiocenter Recent Development Table 163. North America Phage Display Service Revenue by Type (2021-2026) & (US$ Million) Table 164. North America Phage Display Service Revenue by Type (2027-2032) & (US$ Million) Table 165. North America Phage Display Service Revenue by Application (2021-2026) & (US$ Million) Table 166. North America Phage Display Service Revenue by Application (2027-2032) & (US$ Million) Table 167. North America Phage Display Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. North America Phage Display Service Revenue by Country (2021-2026) & (US$ Million) Table 169. North America Phage Display Service Revenue by Country (US$ Million) & (2027-2032) Table 170. Europe Phage Display Service Revenue by Type (2021-2026) & (US$ Million) Table 171. Europe Phage Display Service Revenue by Type (2027-2032) & (US$ Million) Table 172. Europe Phage Display Service Revenue by Application (2021-2026) & (US$ Million) Table 173. Europe Phage Display Service Revenue by Application (2027-2032) & (US$ Million) Table 174. Europe Phage Display Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Europe Phage Display Service Revenue by Country (2021-2026) & (US$ Million) Table 176. Europe Phage Display Service Revenue by Country (US$ Million) & (2027-2032) Table 177. China Phage Display Service Revenue by Type (2021-2026) & (US$ Million) Table 178. China Phage Display Service Revenue by Type (2027-2032) & (US$ Million) Table 179. China Phage Display Service Revenue by Application (2021-2026) & (US$ Million) Table 180. China Phage Display Service Revenue by Application (2027-2032) & (US$ Million) Table 181. Asia Phage Display Service Revenue by Type (2021-2026) & (US$ Million) Table 182. Asia Phage Display Service Revenue by Type (2027-2032) & (US$ Million) Table 183. Asia Phage Display Service Revenue by Application (2021-2026) & (US$ Million) Table 184. Asia Phage Display Service Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia Phage Display Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Asia Phage Display Service Revenue by Region (US$ Million) & (2021-2026) Table 187. Asia Phage Display Service Revenue by Region (US$ Million) & (2027-2032) Table 188. SAMEA Phage Display Service Revenue by Type (2021-2026) & (US$ Million) Table 189. SAMEA Phage Display Service Revenue by Type (2027-2032) & (US$ Million) Table 190. SAMEA Phage Display Service Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Phage Display Service Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Phage Display Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. SAMEA Phage Display Service Revenue by Country (2021-2026) & (US$ Million) Table 194. SAMEA Phage Display Service Revenue by Country (US$ Million) & (2027-2032) Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Phage Display Service Image Figure 2. Global Phage Display Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phage Display Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. cDNA Library Image Figure 5. Antibody Library Image Figure 6. Protein Library Image Figure 7. Random Peptide Library Image Figure 8. Global Phage Display Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Phage Display Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Immunotherapy Image Figure 11. Drug Discovery Image Figure 12. Functional Genomics Image Figure 13. Others Image Figure 14. Global Phage Display Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Phage Display Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Phage Display Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Phage Display Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Phage Display Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Phage Display Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Phage Display Service Revenue Market Share by Type (2021-2032) Figure 22. Global Phage Display Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Phage Display Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Phage Display Service Revenue Market Share by Application (2021-2032) Figure 25. North America Phage Display Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Phage Display Service Revenue Share by Type (2021-2032) Figure 27. North America Phage Display Service Revenue Share by Application (2021-2032) Figure 28. North America Phage Display Service Revenue Share by Country (2021-2032) Figure 29. United States Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Phage Display Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Phage Display Service Revenue Share by Type (2021-2032) Figure 34. Europe Phage Display Service Revenue Share by Application (2021-2032) Figure 35. Europe Phage Display Service Revenue Share by Country (2021-2032) Figure 36. Germany Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Phage Display Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Phage Display Service Revenue Share by Type (2021-2032) Figure 46. China Phage Display Service Revenue Share by Application (2021-2032) Figure 47. Asia Phage Display Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Phage Display Service Revenue Share by Type (2021-2032) Figure 49. Asia Phage Display Service Revenue Share by Application (2021-2032) Figure 50. Asia Phage Display Service Revenue Share by Region (2021-2032) Figure 51. Japan Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Phage Display Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Phage Display Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Phage Display Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Phage Display Service Revenue Share by Country (2021-2032) Figure 61. Brazil Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Phage Display Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • cDNA Library
  • Antibody Library
  • Protein Library
  • Random Peptide Library
Applications
  • Immunotherapy
  • Drug Discovery
  • Functional Genomics
  • Others
Companies covered
  • Creative Biogene
  • Creative Biolabs
  • ProteoGenix
  • CUSABIO
  • Diaclone
  • Biomolecular Discovery Services
  • Charles River
  • GenScript
  • Synbio Technologies
  • Creative Peptides
  • ProImmune
  • Absolute Antibody
  • Iontas
  • LakePharma
  • KMD Bioscience
  • NeoClone
  • Pepscan
  • Abzena
  • ChemPartner
  • Creative Proteomics
  • Yntoab
  • Diane biological
  • Biosynth
  • Zoonbio Biotechnology
  • Abiocenter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Phage Display Service Market by Type
  3. 1.2.1 Global Phage Display Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 cDNA Library
  5. 1.2.3 Antibody Library
  6. 1.2.4 Protein Library
  7. 1.2.5 Random Peptide Library
  8. 1.3 Phage Display Service Market by Application
  9. 1.3.1 Global Phage Display Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Immunotherapy
  11. 1.3.3 Drug Discovery
  12. 1.3.4 Functional Genomics
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Phage Display Service Market Dynamics
  1. 2.1 Phage Display Service Industry Trends
  2. 2.2 Phage Display Service Industry Drivers
  3. 2.3 Phage Display Service Industry Opportunities and Challenges
  4. 2.4 Phage Display Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Phage Display Service Market Perspective (2021-2032)
  2. 3.2 Global Phage Display Service Growth Trends by Region
  3. 3.2.1 Global Phage Display Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Phage Display Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Phage Display Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Phage Display Service Revenue by Players
  2. 4.1.1 Global Phage Display Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Phage Display Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Phage Display Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Phage Display Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Phage Display Service Key Players Headquarters & Area Served
  7. 4.4 Global Phage Display Service Players, Product Type & Application
  8. 4.5 Global Phage Display Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Phage Display Service Market CR5 and HHI
  11. 4.6.3 2025 Phage Display Service Tier 1, Tier 2, and Tier 3
5 Phage Display Service Market Size by Type
  1. 5.1 Global Phage Display Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Phage Display Service Revenue by Type (2021-2032)
  3. 5.3 Global Phage Display Service Revenue Market Share by Type (2021-2032)
6 Phage Display Service Market Size by Application
  1. 6.1 Global Phage Display Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Phage Display Service Revenue by Application (2021-2032)
  3. 6.3 Global Phage Display Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Creative Biogene
  2. 7.1.1 Creative Biogene Company Information
  3. 7.1.2 Creative Biogene Business Overview
  4. 7.1.3 Creative Biogene Phage Display Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Creative Biogene Phage Display Service Product Portfolio
  6. 7.1.5 Creative Biogene Recent Developments
  7. 7.2 Creative Biolabs
  8. 7.2.1 Creative Biolabs Company Information
  9. 7.2.2 Creative Biolabs Business Overview
  10. 7.2.3 Creative Biolabs Phage Display Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Creative Biolabs Phage Display Service Product Portfolio
  12. 7.2.5 Creative Biolabs Recent Developments
  13. 7.3 ProteoGenix
  14. 7.3.1 ProteoGenix Company Information
  15. 7.3.2 ProteoGenix Business Overview
  16. 7.3.3 ProteoGenix Phage Display Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 ProteoGenix Phage Display Service Product Portfolio
  18. 7.3.5 ProteoGenix Recent Developments
  19. 7.4 CUSABIO
  20. 7.4.1 CUSABIO Company Information
  21. 7.4.2 CUSABIO Business Overview
  22. 7.4.3 CUSABIO Phage Display Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CUSABIO Phage Display Service Product Portfolio
  24. 7.4.5 CUSABIO Recent Developments
  25. 7.5 Diaclone
  26. 7.5.1 Diaclone Company Information
  27. 7.5.2 Diaclone Business Overview
  28. 7.5.3 Diaclone Phage Display Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Diaclone Phage Display Service Product Portfolio
  30. 7.5.5 Diaclone Recent Developments
  31. 7.6 Biomolecular Discovery Services
  32. 7.6.1 Biomolecular Discovery Services Company Information
  33. 7.6.2 Biomolecular Discovery Services Business Overview
  34. 7.6.3 Biomolecular Discovery Services Phage Display Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Biomolecular Discovery Services Phage Display Service Product Portfolio
  36. 7.6.5 Biomolecular Discovery Services Recent Developments
  37. 7.7 Charles River
  38. 7.7.1 Charles River Company Information
  39. 7.7.2 Charles River Business Overview
  40. 7.7.3 Charles River Phage Display Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Charles River Phage Display Service Product Portfolio
  42. 7.7.5 Charles River Recent Developments
  43. 7.8 GenScript
  44. 7.8.1 GenScript Company Information
  45. 7.8.2 GenScript Business Overview
  46. 7.8.3 GenScript Phage Display Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 GenScript Phage Display Service Product Portfolio
  48. 7.8.5 GenScript Recent Developments
  49. 7.9 Synbio Technologies
  50. 7.9.1 Synbio Technologies Company Information
  51. 7.9.2 Synbio Technologies Business Overview
  52. 7.9.3 Synbio Technologies Phage Display Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Synbio Technologies Phage Display Service Product Portfolio
  54. 7.9.5 Synbio Technologies Recent Developments
  55. 7.10 Creative Peptides
  56. 7.10.1 Creative Peptides Company Information
  57. 7.10.2 Creative Peptides Business Overview
  58. 7.10.3 Creative Peptides Phage Display Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Creative Peptides Phage Display Service Product Portfolio
  60. 7.10.5 Creative Peptides Recent Developments
  61. 7.11 ProImmune
  62. 7.11.1 ProImmune Company Information
  63. 7.11.2 ProImmune Business Overview
  64. 7.11.3 ProImmune Phage Display Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 ProImmune Phage Display Service Product Portfolio
  66. 7.11.5 ProImmune Recent Developments
  67. 7.12 Absolute Antibody
  68. 7.12.1 Absolute Antibody Company Information
  69. 7.12.2 Absolute Antibody Business Overview
  70. 7.12.3 Absolute Antibody Phage Display Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Absolute Antibody Phage Display Service Product Portfolio
  72. 7.12.5 Absolute Antibody Recent Developments
  73. 7.13 Iontas
  74. 7.13.1 Iontas Company Information
  75. 7.13.2 Iontas Business Overview
  76. 7.13.3 Iontas Phage Display Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Iontas Phage Display Service Product Portfolio
  78. 7.13.5 Iontas Recent Developments
  79. 7.14 LakePharma
  80. 7.14.1 LakePharma Company Information
  81. 7.14.2 LakePharma Business Overview
  82. 7.14.3 LakePharma Phage Display Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 LakePharma Phage Display Service Product Portfolio
  84. 7.14.5 LakePharma Recent Developments
  85. 7.15 KMD Bioscience
  86. 7.15.1 KMD Bioscience Company Information
  87. 7.15.2 KMD Bioscience Business Overview
  88. 7.15.3 KMD Bioscience Phage Display Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 KMD Bioscience Phage Display Service Product Portfolio
  90. 7.15.5 KMD Bioscience Recent Developments
  91. 7.16 NeoClone
  92. 7.16.1 NeoClone Company Information
  93. 7.16.2 NeoClone Business Overview
  94. 7.16.3 NeoClone Phage Display Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 NeoClone Phage Display Service Product Portfolio
  96. 7.16.5 NeoClone Recent Developments
  97. 7.17 Pepscan
  98. 7.17.1 Pepscan Company Information
  99. 7.17.2 Pepscan Business Overview
  100. 7.17.3 Pepscan Phage Display Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Pepscan Phage Display Service Product Portfolio
  102. 7.17.5 Pepscan Recent Developments
  103. 7.18 Abzena
  104. 7.18.1 Abzena Company Information
  105. 7.18.2 Abzena Business Overview
  106. 7.18.3 Abzena Phage Display Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Abzena Phage Display Service Product Portfolio
  108. 7.18.5 Abzena Recent Developments
  109. 7.19 ChemPartner
  110. 7.19.1 ChemPartner Company Information
  111. 7.19.2 ChemPartner Business Overview
  112. 7.19.3 ChemPartner Phage Display Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 ChemPartner Phage Display Service Product Portfolio
  114. 7.19.5 ChemPartner Recent Developments
  115. 7.20 Creative Proteomics
  116. 7.20.1 Creative Proteomics Company Information
  117. 7.20.2 Creative Proteomics Business Overview
  118. 7.20.3 Creative Proteomics Phage Display Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Creative Proteomics Phage Display Service Product Portfolio
  120. 7.20.5 Creative Proteomics Recent Developments
  121. 7.21 Yntoab
  122. 7.21.1 Yntoab Company Information
  123. 7.21.2 Yntoab Business Overview
  124. 7.21.3 Yntoab Phage Display Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Yntoab Phage Display Service Product Portfolio
  126. 7.21.5 Yntoab Recent Developments
  127. 7.22 Diane biological
  128. 7.22.1 Diane biological Company Information
  129. 7.22.2 Diane biological Business Overview
  130. 7.22.3 Diane biological Phage Display Service Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Diane biological Phage Display Service Product Portfolio
  132. 7.22.5 Diane biological Recent Developments
  133. 7.23 Biosynth
  134. 7.23.1 Biosynth Company Information
  135. 7.23.2 Biosynth Business Overview
  136. 7.23.3 Biosynth Phage Display Service Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Biosynth Phage Display Service Product Portfolio
  138. 7.23.5 Biosynth Recent Developments
  139. 7.24 Zoonbio Biotechnology
  140. 7.24.1 Zoonbio Biotechnology Company Information
  141. 7.24.2 Zoonbio Biotechnology Business Overview
  142. 7.24.3 Zoonbio Biotechnology Phage Display Service Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Zoonbio Biotechnology Phage Display Service Product Portfolio
  144. 7.24.5 Zoonbio Biotechnology Recent Developments
  145. 7.25 Abiocenter
  146. 7.25.1 Abiocenter Company Information
  147. 7.25.2 Abiocenter Business Overview
  148. 7.25.3 Abiocenter Phage Display Service Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Abiocenter Phage Display Service Product Portfolio
  150. 7.25.5 Abiocenter Recent Developments
8 North America
  1. 8.1 North America Phage Display Service Revenue (2021-2032)
  2. 8.2 North America Phage Display Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Phage Display Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Phage Display Service Revenue by Type (2027-2032)
  5. 8.3 North America Phage Display Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Phage Display Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Phage Display Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Phage Display Service Revenue by Application (2027-2032)
  9. 8.5 North America Phage Display Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Phage Display Service Revenue by Country
  11. 8.6.1 North America Phage Display Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Phage Display Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Phage Display Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Phage Display Service Revenue (2021-2032)
  2. 9.2 Europe Phage Display Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Phage Display Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Phage Display Service Revenue by Type (2027-2032)
  5. 9.3 Europe Phage Display Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Phage Display Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Phage Display Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Phage Display Service Revenue by Application (2027-2032)
  9. 9.5 Europe Phage Display Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Phage Display Service Revenue by Country
  11. 9.6.1 Europe Phage Display Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Phage Display Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Phage Display Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Phage Display Service Revenue (2021-2032)
  2. 10.2 China Phage Display Service Revenue by Type (2021-2032)
  3. 10.2.1 China Phage Display Service Revenue by Type (2021-2026)
  4. 10.2.2 China Phage Display Service Revenue by Type (2027-2032)
  5. 10.3 China Phage Display Service Revenue Share by Type (2021-2032)
  6. 10.4 China Phage Display Service Revenue by Application (2021-2032)
  7. 10.4.1 China Phage Display Service Revenue by Application (2021-2026)
  8. 10.4.2 China Phage Display Service Revenue by Application (2027-2032)
  9. 10.5 China Phage Display Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Phage Display Service Revenue (2021-2032)
  2. 11.2 Asia Phage Display Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Phage Display Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Phage Display Service Revenue by Type (2027-2032)
  5. 11.3 Asia Phage Display Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Phage Display Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Phage Display Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Phage Display Service Revenue by Application (2027-2032)
  9. 11.5 Asia Phage Display Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Phage Display Service Revenue by Country
  11. 11.6.1 Asia Phage Display Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Phage Display Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Phage Display Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Phage Display Service Revenue (2021-2032)
  2. 12.2 SAMEA Phage Display Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Phage Display Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Phage Display Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Phage Display Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Phage Display Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Phage Display Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Phage Display Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Phage Display Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Phage Display Service Revenue by Country
  11. 12.6.1 SAMEA Phage Display Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Phage Display Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Phage Display Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst